157 related articles for article (PubMed ID: 17766109)
21. Control of bacterial biofilms with marine alkaloid derivatives.
Huigens RW; Ma L; Gambino C; Moeller PD; Basso A; Cavanagh J; Wozniak DJ; Melander C
Mol Biosyst; 2008 Jun; 4(6):614-21. PubMed ID: 18493660
[TBL] [Abstract][Full Text] [Related]
22. Novel and potent oxazolidinone antibacterials featuring 3-indolylglyoxamide substituents.
Takhi M; Singh G; Murugan C; Thaplyyal N; Maitra S; Bhaskarreddy KM; Amarnath PV; Mallik A; Harisudan T; Trivedi RK; Sreenivas K; Selvakumar N; Iqbal J
Bioorg Med Chem Lett; 2008 Sep; 18(18):5150-5. PubMed ID: 18768315
[TBL] [Abstract][Full Text] [Related]
23. 2,3,4,5-Tetrahydro-1H-pyrido[2,3-b and e][1,4]diazepines as inhibitors of the bacterial enoyl ACP reductase, FabI.
Ramnauth J; Surman MD; Sampson PB; Forrest B; Wilson J; Freeman E; Manning DD; Martin F; Toro A; Domagala M; Awrey DE; Bardouniotis E; Kaplan N; Berman J; Pauls HW
Bioorg Med Chem Lett; 2009 Sep; 19(18):5359-62. PubMed ID: 19682900
[TBL] [Abstract][Full Text] [Related]
24. New DNA polymerase IIIC inhibitors: 3-subtituted anilinouracils with potent antibacterial activity in vitro and in vivo.
Svenstrup N; Ehlert K; Ladel C; Kuhl A; Häbich D
ChemMedChem; 2008 Oct; 3(10):1604-15. PubMed ID: 18792034
[TBL] [Abstract][Full Text] [Related]
25. Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships.
Charifson PS; Grillot AL; Grossman TH; Parsons JD; Badia M; Bellon S; Deininger DD; Drumm JE; Gross CH; LeTiran A; Liao Y; Mani N; Nicolau DP; Perola E; Ronkin S; Shannon D; Swenson LL; Tang Q; Tessier PR; Tian SK; Trudeau M; Wang T; Wei Y; Zhang H; Stamos D
J Med Chem; 2008 Sep; 51(17):5243-63. PubMed ID: 18690678
[TBL] [Abstract][Full Text] [Related]
26. Structure-guided design, synthesis and biological evaluation of novel DNA ligase inhibitors with in vitro and in vivo anti-staphylococcal activity.
Surivet JP; Lange R; Hubschwerlen C; Keck W; Specklin JL; Ritz D; Bur D; Locher H; Seiler P; Strasser DS; Prade L; Kohl C; Schmitt C; Chapoux G; Ilhan E; Ekambaram N; Athanasiou A; Knezevic A; Sabato D; Chambovey A; Gaertner M; Enderlin M; Boehme M; Sippel V; Wyss P
Bioorg Med Chem Lett; 2012 Nov; 22(21):6705-11. PubMed ID: 23006603
[TBL] [Abstract][Full Text] [Related]
27. Structure-based discovery and experimental verification of novel AI-2 quorum sensing inhibitors against Vibrio harveyi.
Li M; Ni N; Chou HT; Lu CD; Tai PC; Wang B
ChemMedChem; 2008 Aug; 3(8):1242-9. PubMed ID: 18537200
[TBL] [Abstract][Full Text] [Related]
28. Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors.
Sangwan PL; Koul JL; Koul S; Reddy MV; Thota N; Khan IA; Kumar A; Kalia NP; Qazi GN
Bioorg Med Chem; 2008 Nov; 16(22):9847-57. PubMed ID: 18848780
[TBL] [Abstract][Full Text] [Related]
29. Overcoming the unexpected functional inversion of a PqsR antagonist in Pseudomonas aeruginosa: an in vivo potent antivirulence agent targeting pqs quorum sensing.
Lu C; Maurer CK; Kirsch B; Steinbach A; Hartmann RW
Angew Chem Int Ed Engl; 2014 Jan; 53(4):1109-12. PubMed ID: 24338917
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of some novel imidazole-based dicationic carbazolophanes as potential antibacterials.
Rajakumar P; Sekar K; Shanmugaiah V; Mathivanan N
Bioorg Med Chem Lett; 2008 Aug; 18(15):4416-9. PubMed ID: 18620857
[TBL] [Abstract][Full Text] [Related]
31. Siderophores as drug delivery agents: application of the "Trojan Horse" strategy.
Möllmann U; Heinisch L; Bauernfeind A; Köhler T; Ankel-Fuchs D
Biometals; 2009 Aug; 22(4):615-24. PubMed ID: 19214755
[TBL] [Abstract][Full Text] [Related]
32. Inhibition and dispersion of Pseudomonas aeruginosa biofilms with reverse amide 2-aminoimidazole oroidin analogues.
Richards JJ; Ballard TE; Melander C
Org Biomol Chem; 2008 Apr; 6(8):1356-63. PubMed ID: 18385842
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Acinetobacter baumannii, Staphylococcus aureus and Pseudomonas aeruginosa biofilm formation with a class of TAGE-triazole conjugates.
Huigens RW; Rogers SA; Steinhauer AT; Melander C
Org Biomol Chem; 2009 Feb; 7(4):794-802. PubMed ID: 19194596
[TBL] [Abstract][Full Text] [Related]
34. Small molecule inhibitors of E. coli primase, a novel bacterial target.
Agarwal A; Louise-May S; Thanassi JA; Podos SD; Cheng J; Thoma C; Liu C; Wiles JA; Nelson DM; Phadke AS; Bradbury BJ; Deshpande MS; Pucci MJ
Bioorg Med Chem Lett; 2007 May; 17(10):2807-10. PubMed ID: 17350255
[TBL] [Abstract][Full Text] [Related]
35. Preparation and in vitro anti-staphylococcal activity of novel 11-deoxy-11-hydroxyiminorifamycins.
Li J; Ma Z; Chapo K; Yan D; Lynch AS; Ding CZ
Bioorg Med Chem Lett; 2007 Oct; 17(20):5510-3. PubMed ID: 17826091
[TBL] [Abstract][Full Text] [Related]
36. Antibacterial alkoxybenzamide inhibitors of the essential bacterial cell division protein FtsZ.
Czaplewski LG; Collins I; Boyd EA; Brown D; East SP; Gardiner M; Fletcher R; Haydon DJ; Henstock V; Ingram P; Jones C; Noula C; Kennison L; Rockley C; Rose V; Thomaides-Brears HB; Ure R; Whittaker M; Stokes NR
Bioorg Med Chem Lett; 2009 Jan; 19(2):524-7. PubMed ID: 19064318
[TBL] [Abstract][Full Text] [Related]
37. N-Hydroxybenzimidazole inhibitors of ExsA MAR transcription factor in Pseudomonas aeruginosa: In vitro anti-virulence activity and metabolic stability.
Grier MC; Garrity-Ryan LK; Bartlett VJ; Klausner KA; Donovan PJ; Dudley C; Alekshun MN; Tanaka SK; Draper MP; Levy SB; Kim OK
Bioorg Med Chem Lett; 2010 Jun; 20(11):3380-3. PubMed ID: 20434913
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and antibacterial activity of novel actinonin derivatives containing benzimidazole heterocycles.
Zhang D; Wang Z; Xu W; Sun F; Tang L; Wang J
Eur J Med Chem; 2009 May; 44(5):2202-10. PubMed ID: 18617291
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, structure and antibacterial activity of novel 1-(5-substituted-3-substituted-4,5-dihydropyrazol-1-yl)ethanone oxime ester derivatives.
Liu XH; Cui P; Song BA; Bhadury PS; Zhu HL; Wang SF
Bioorg Med Chem; 2008 Apr; 16(7):4075-82. PubMed ID: 18262793
[TBL] [Abstract][Full Text] [Related]
40. Development and characterization of improved β-lactone-based anti-virulence drugs targeting ClpP.
Zeiler E; Korotkov VS; Lorenz-Baath K; Böttcher T; Sieber SA
Bioorg Med Chem; 2012 Jan; 20(2):583-91. PubMed ID: 21855356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
